Management of ischemic heart disease in catheterization laboratories during the health contingency generated by the COVID-19 pandemic. Recommendations of the Mexican Interventional Cardiology Society (SOCIME)

• Published in: REC, Interventional cardiology (Internet. English ed.) Vol. 2; no. 3; pp. 199 - 205
• Main Authors: Piña-Reyna, Yigal, García-Rincón, Andrés, Ortiz-Fernández, Patricio Heriberto, Alcocer-Gambav, Marco Antonio, Gutiérrez-Fajardo, Pedro, Merino-Rajme, José Alfredo, Reyes-Terán, Gustavo
• Format: Journal Article
• Language: English
• Published: Permanyer 01.07.2020
• Subjects: Acute coronary syndrome; COVID-19; Myocardial infarction; Pandemic; Percutaneous coronary intervention; SARS-CoV-2
• ISSN: 2604-7322; 2604-7322
• DOI: 10.24875/RECICE.M20000126

Abstract In Mexico, the number of confirmed and estimated cases of COVID-19 has been going up gradually from the second week of March 2020. This directly and indirectly altered the normal care of patients with ischemic heart disease. This is a consensus document achieved by different societies (the Mexican Society of Interventional Cardiology [SOCIME], the Mexican Society of Cardiology [SMC], the Mexican National Association of Cardiologists [ANCAM], the National Association of Cardiologists at the Service of State Workers [ANCISSSTE]), and the Coordinating Commission of National Institutes of Health and High Specialty Hospitals [CCINSHAE]). Its main objective is to guide the decision-making process on coronary revascularization procedures for the management of patients with acute coronary syndrome in catheterization laboratories during the current health emergency generated by the SARS-CoV-2 pandemic.